Indoco Remedies

Indoco Remedies ROE

The Return on Equity (ROE) of Indoco Remedies (INDOCO.NS) as of Oct 21, 2026 is -10.51 %. In the previous year, Return on Equity (ROE) was -7.22 % — a change of 45.64% (lower).

ROE

-10.51 %

YoY

45.64%

Last updated:

In 2026, Indoco Remedies's return on equity (ROE) was -10.51 %, a 45.64% increase from the -7.22 % ROE in the previous year.

The Indoco Remedies ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
-0.44 INR
Jan 1, 2020
3.55 INR
Jan 1, 2021
12.10 INR
Jan 1, 2022
17.11 INR
Jan 1, 2023
13.83 INR
Jan 1, 2024
8.87 INR
Jan 1, 2025
-7.22 INR
Jan 1, 2026
-10.51 INR
The Indoco Remedies ROE history
YEARROEYoY
-10.51 %+45.64%
-7.22 %-181.33%
8.87 %-35.88%
13.83 %-19.15%
17.11 %+41.42%
12.10 %+240.94%
3.55 %-907.33%
-0.44 %-107.21%
6.10 %-48.44%
11.83 %-16.72%
14.20 %-11.03%
15.96 %+25.85%
12.68 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Indoco Remedies Stock analysis

What does Indoco Remedies do? Indoco Remedies Ltd. manufactures and markets formulations and active pharmaceutical ingredients, offering medicines across therapeutic categories like diabetology, respiratory, and women's health. Its product portfolio includes brands such as Cyclopam, Sensodent-K, Karvol Plus, and Rexidin M, targeting both domestic and international markets. The company serves healthcare providers and consumers through its extensive range of pharmaceutical products, with subsidiaries supporting its global operations. The firm's revenue streams derive from the sale of finished dosage forms and APIs, with key brands like Cital UTI and Kidodent catering to specific medical needs. International markets represent a significant segment, complementing domestic sales, while subsidiaries such as Indoco Remedies Czech sro and Indoco Remedies UK Limited facilitate regional distribution and market expansion. Products like Lignox A and Homide are positioned for niche therapeutic applications, driving demand among healthcare professionals and patients. Indoco Remedies is one of the most popular companies on Eulerpool.

ROE Details

Decoding Indoco Remedies's Return on Equity (ROE)

Indoco Remedies's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Indoco Remedies's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Indoco Remedies's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Indoco Remedies’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Indoco Remedies stock

Return on Equity (ROE) of Indoco Remedies is -10.51 % in 2026.

Return on Equity (ROE) of Indoco Remedies changed from -7.22 % to -10.51 %, representing a 45.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Indoco Remedies since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Indoco Remedies with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Indoco Remedies

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Indoco Remedies